Form D · Pharmaceuticals
Timber Pharmaceuticals, Inc.
Basking Ridge, NJ · CIK 0001504167
Offering snapshot reported Oct 11, 2022 · SEC filing
- Reported sold
- $0 Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 3, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 11, 2022 | Initial | $0 | No comparison | 2 | SEC filing |
| Oct 7, 2016 | Initial | $930,000 | No comparison | 5 | SEC filing |
| Mar 19, 2015 | Initial | $134,332 | No comparison | 16 | SEC filing |
| Mar 19, 2015 | Amendment | $7,869,775 | $6,369,775vs Apr 18, 2014 | 51 | SEC filing |
| Mar 19, 2015 | Initial | $508,468 | No comparison | 1 | SEC filing |
| Mar 18, 2015 | Initial | $1,750,000 | No comparison | 25 | SEC filing |
| Apr 18, 2014 | Initial | $1,500,000 | No comparison | 2 | SEC filing |
| Jan 31, 2014 | Initial | $7,025 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-461387
Value of preferred stock and private placement warrants indeterminable as they were issued in connection with a concurrent registered direct offering of common stock and warrants.
See Item 13. Fees payable to placement agent solely for the issuance of the preferred stock and private placement warrants indeterminable.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co. LLC | 375 |
Source: Form D, filed Oct 11, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kin Chan | Executive |
| David E. Cohen | Director |
| Lubor Gaal | Director |
| Michael Hubbard | Director |
| Greg Kitchener | Executive |
| John Koconis | Director, Executive |
| Anja Krammer | Director, Executive |
| Joseph Lucchese | Executive |
| Alan M. Mendelsohn | Executive |
| Stephen Morlock | Director |
| James Pekarsky | Director, Executive |
| Gianluca Pirozzi | Director |
| Edward J. Sitar | Director |
| Ping Wang | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
110 Allen Road Suite 401
Basking Ridge, NJ, 07920
Basking Ridge, NJ, 07920